H35.139
Retinopathy of prematurity, stage 2, unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Retinopathy of prematurity (ROP) is a condition that affects the eyes of premature infants, influencing the development of their retinas—the light-sensitive tissue at the back of the eye. Specifically, stage 2 ROP signifies a moderate progression in this condition. Though it typically occurs in one or both eyes of premature babies, early detection and monitoring are essential to prevent potential vision problems. This overview provides an accessible explanation of ICD-10 code H35.139, detailing causes, symptoms, diagnosis, and management options.
Causes & Symptoms
Clinical Causes: Retinopathy of prematurity develops primarily in premature infants due to incomplete blood vessel development in the retina during early gestation. Factors influencing its occurrence include: - Premature birth (born before 31 weeks of gestation) - Low birth weight (less than 1500 grams) - Fluctuations in oxygen levels, whether too high or too low - Use of supplemental oxygen therapy - Rapid growth or instability in a newborn's health condition - Genetic predispositions, although less clearly understood The immature blood vessels in premature babies’ eyes can sometimes grow abnormally, leading to ROP.
Key Symptoms: Since ROP develops in infants, signs of concern might include: - Abnormal eye movements - Decreased responsiveness to visual stimuli - Poor visual tracking - Abnormal eye appearance, such as crossed eyes or misaligned pupils - Noticing unusual eye redness or swelling (though less common) However, many infants with ROP may have no obvious outward symptoms initially, which highlights the importance of regular eye examinations for premature infants.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by a pediatric ophthalmologist, often between 4 to 9 weeks after birth. The process includes: - Indirect ophthalmoscopy, where a special instrument allows the doctor to view the retina - Retinal imaging to document the extent of abnormal blood vessel growth - Grading the stage of ROP based on severity and location Since this condition can progress quickly, timely screening and monitoring are critical in managing the disease effectively.
Treatment Protocols: Management of stage 2 ROP focuses on preventing progression to more severe stages that threaten vision. Treatment methods include: - Laser therapy (photocoagulation), which targets abnormal blood vessels to prevent their growth - Cryotherapy, an older method involving freezing abnormal vessels - Anti-VEGF (vascular endothelial growth factor) injections, which inhibit abnormal vessel formation - Vigilant observation for cases that may regress spontaneously The specific treatment approach depends on the individual case, the extent of abnormal blood vessel growth, and the risk of progression. Early intervention can significantly reduce the risk of long-term visual impairment.
Clinical Advice & FAQs
Billing Guidance
Is H35.139 a billable ICD-10 code?
Yes, H35.139 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.139?
Clinical documentation must specify the nature of Retinopathy of prematurity, stage 2, unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference